The clinical information you need, at your fingertips.

Most adults with anxiety seek care in primary care settings, where stepped treatment matched to symptom severity consistently outperforms usual care. . .

People with worse mental health report more discrimination, lower-quality care, and less confidence in health systems, suggesting a consistent experience gap that extends beyond access to services. . .

U.S. bariatric procedures fell more than 20% in a single year, the steepest decline since the early pandemic, even as obesity prevalence remained high. . .

Even as GLP‑1 use surged to 1.4 million prescriptions, up to 95% of severe obesity cases received no therapy. . .

Total two-year price for sleeve gastrectomy and gastric bypass ran thousands of dollars below those for GLP-1 therapy in patients with obesity and type 2 diabetes. . .

Patients with obesity and chronic kidney disease who underwent bariatric surgery had roughly half the risk of progressing to kidney failure and a fraction of the mortality seen in matched non-surgical patients over five years. . .

The new extended‑release formulation of ruxolitinib delivers sustained drug levels over 24 hours. . .

Struggling to afford housing was independently linked to higher five-year risks of frailty, disability, dementia, and death in a nationally representative cohort of older Americans. Living in poor-quality housing carried similar risks. . .

Previously treated metastatic pancreatic cancer patients may be eligible for daraxonrasib outside clinical trials. . .